Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis
|ClinicalTrials.gov Identifier: NCT00889902|
Recruitment Status : Unknown
Verified April 2009 by Wuhan University.
Recruitment status was: Not yet recruiting
First Posted : April 29, 2009
Last Update Posted : April 29, 2009
The purpose of this study is to:
- make p16INK4A as a cervical cancer screening of tumor markers, cytology improve existing diagnostic sensitivity, specificity, repeatability and validity, so as to effectively prompted the early discovery and diagnosis of cervical cancer.
- reduce screening costs, screening and benefits into quantitative evaluation, for our country to develop cervical cancer prevention and control strategy to provide a reliable theoretical basis.
|Condition or disease|
- To carry out large-scale prospective randomized controlled clinical study to evaluate the "cytological molecular markers Detect + P16INK4A" methods of screening accuracy and reliability, as well as the screening method of the biological effects.
- Markov set up mathematical model of screening tests to quantify the inputs and the evaluation proceeds. With a view to optimize and perfect a simple, convenient, practical and efficient program of cervical cancer screening.
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Observational Model:||Case Control|
|Official Title:||Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis|
|Study Start Date :||April 2009|
|Estimated Primary Completion Date :||June 2010|
|Estimated Study Completion Date :||July 2011|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00889902
|Contact: Hong B Cai, Doctor||0086-027-67813044||Chb2105@163.com|
|Contact: Ying J Huang|
|Wufeng county, Hubei, China|
|Study Director:||Hong B Cai, Doctor||gynecologic oncology department, Zhongnan Hospital of Wuhan University|